Compare AbbVie Inc (ABBV) vs American States Water Company (AWR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbbVie Inc vs American States Water Company — how do they compare? AbbVie Inc trades at $247.6 (market cap $441.94B), while American States Water Company trades at $87.53 (market cap $3.47B). The key difference: AbbVie Inc is far larger — about 127.4× American States Water Company's market cap, and AbbVie Inc pays the higher dividend (2.77%). Which is the better fit depends on your goals.
| ABBV | AWR | |
|---|---|---|
Market Cap | $441.94B | $3.47B |
Sector | Health | Utilities |
52-Week High | $263.58 | $89.28 |
52-Week Low | $197.38 | $70.10 |
Enterprise Value | $506.19B | $4.37B |
Dividend Yield | 2.77% | 2.49% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbbVie (ABBV) trades at $249.9, up 0.8% on the day, with strong analyst support (29 Buy, 1 Sell) and a $278.69 consensus price target. Recent quarterly earnings have consistently beaten estimates, driven by robust immunology drug sales. The stock shows a bullish technical trend, supported by moving averages, and the company maintains solid cash flow and dividend payments.
Outlook is positive with revenue growth and pipeline advancements, though high P/E and debt levels pose risks. The stock offers a compelling buy case for growth and income investors, balanced by execution and patent expiry challenges ahead.
American States Water (AWR) trades at $87.83, up 1.46% today, with strong technical momentum as moving averages signal bullish alignment. The company maintains robust fundamentals with 20.52% net income margin and consistent dividend growth, recently increasing its quarterly payout by 8.2%. Recent Q2 2026 earnings beat expectations at $1.09 per share, driven by water rate increases and operational gains across business segments.
Outlook remains stable with revenue growth and dividend reliability, though valuation multiples appear elevated versus utilities peers. Key risks include regulatory dependence on rate approvals and competitive pressures. Analyst sentiment is mixed with 20% buy ratings amid concerns about current price levels relative to earnings potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbbVie Inc
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Read more on ABBV →About American States Water Company
American States Water provides water and electric services to over one million people in the U.S. It also manages water and wastewater systems for various military bases under long-term privatization contracts.
Read more on AWR →
